Business Development Director (Life Sciences - Regulatory Affairs)

Visium seeks a Business Development Director to lead commercial growth for its AI-driven regulatory document platform, Scribe, targeting pharmaceutical and biotech clients in Zürich.

This position serves as the main commercial lead for Visium’s Scribe platform, an AI agent system designed specifically for drafting regulatory documents in the Life Sciences sector. The director will drive enterprise client acquisition and act as the primary liaison for pharmaceutical and biotech organizations aiming to speed up submissions, cut down authoring time, and ensure strict adherence to FDA, EMA, and GxP standards.

Responsibilities

• Identify and secure new enterprise accounts within pharmaceuticals, biotechnology, medtech, and healthcare regulatory functions.
• Execute strategic outbound campaigns, including executive networking, thought leadership, and direct outreach to heads of Regulatory Affairs, CMC, and Clinical Operations.
• Evaluate and prioritize leads to match Scribe’s capabilities with client needs regarding submission schedules, automation goals, and compliance targets.
• Lead discovery sessions with VP and Head-level stakeholders in Quality, R&D, and Regulatory Affairs to uncover bottlenecks in submission processes and authoring workflows.
• Create customized proposals and presentations that illustrate how Scribe speeds up the production of documents like CTD modules, CSRs, APQRs, and GVDs while keeping human experts in control.
• Partner with delivery and product teams to ensure smooth onboarding, template configuration, and integration with client data systems, focusing on measurable efficiency gains.
• Stay current with regulatory landscapes, including FDA and EMA guidance updates, AI-assisted workflow trends, and competitor activities in regulatory technology.
• Mentor junior business development staff to build their commercial skills and domain knowledge in Life Sciences regulatory affairs.
• Foster cross-functional collaboration among sales, marketing, and delivery teams to enhance client impact and expand Scribe’s market presence.
• Set performance targets, monitor pipeline health, and provide market insights to refine team effectiveness and go-to-market strategies.

Requirements

• 6–8 years of experience in business development, client engagement, or strategic consulting within the Life Sciences industry, with hands-on exposure to regulatory, quality, or clinical areas.
• Demonstrated success in acquiring enterprise clients and driving revenue growth in complex, regulated sectors, preferably with experience selling software, AI, or tech solutions to regulatory or quality teams.
• Solid grasp of regulatory submission processes, key document types (CTD, CSR, APQR, GVD), and compliance frameworks (FDA, EMA, GxP).
• Strong communication, presentation, and relationship-building abilities, with experience engaging VP and C-level executives in regulated environments.
• Entrepreneurial mindset, strategic thinking capabilities, and a results-driven approach, comfortable working in a fast-growing, product-led organization.
• Fluent proficiency in English.

Nice to have

• Proficiency in German or French is highly valued due to Visium’s European client base.

What the company offers

• A competitive compensation package
• An annual education budget to support continuous learning
• An annual sports budget to promote physical well-being
• A flexible work environment that prioritizes work-life balance
• An international, knowledgeable, and passionate team with a strong collaborative culture

About the company

Visium integrates strategy, frontier AI, and deep expertise in regulated industries to build and deploy AI-native systems that transform business operations. The company focuses on delivering productized AI solutions that compound in value, rather than point solutions or marginal gains. Visium is AI-native, redesigning workflows with AI at the core instead of bolting AI onto existing processes.

• Visium combines strategy, technical integration expertise, and product development into a unified approach.
• The company is obsessed with outcomes, aiming to be the small percentage of enterprise AI initiatives that reach production and deliver sustained value.
• Visium is AI-native, not AI-adjacent, focusing on redesigning workflows with AI at the core rather than adding AI to broken processes.